Update on the NAEPPCC Asthma Guidelines: The wait is over, or is it?

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

卷:146

Article

Szefler, Stanley J.^1,2 

[1] Univ Colorado, Sch Med, Childrens Hosp Colorado, Breathing Inst, Aurora, CO USA

[2] Univ Colorado, Sch Med, Childrens Hosp Colorado, Sect Pediat Pulm & Sleep Med, Aurora, CO USA

关键词: asthma guidelines;    bronchial thermoplasty;    inhaled corticosteroids;    long-acting beta-agonists;    long-acting muscarinic agents;    short-acting beta-agonists;    tiotropium;   

DOI  :  10.1016/j.jaci.2020.01.025

来源: Elsevier

【 摘 要 】

As an asthma specialist, one is often asked to discuss the asthma guidelines. The challenge that one faces is deciding which guidelines to use as a resource for discussion or presentation. It often comes down to the following questions: What is the question? What message does one want to deliver? Where is the most current information? and Who is the target audience? This commentary will help answer those questions as it guides the reader through the new update of the National Heart, Lung and Blood Institute/National Asthma Education and Prevention Program guidelines and then outlines differences between 2 widely used strategies for the management of asthma: the Global Initiative for Asthma and the National Heart, Lung and Blood Institute/National Asthma Education and Prevention Program Guidelines for the Diagnosis and Management of Asthma.

【 授权许可】

Free